brryh, I think that PBT2 is too big for the Fund. It could perhaps support a ph3 study for PBT2 as for the otitis study of Dr. Neville. The deal needs to be made with big pharma, IMO. But this big deal is very complex. I think that all big players such as Pfizer, Novartis, TEVA, J&J, etc will get a territory or two for penicillin, ampicillin, tetracycline, etc around the world. If every company would gain something, it would be easier to find a solution but some companies producing generic drugs will lose without PBT2. Losing a vital business is not easy to accept.
But I cannot advise Uniquest. They know that without a deal there will be more dead people. They have been negotiating now for some 15 months. Results must be ready quite soon, even the deal will be complex.
- Forums
- ASX - By Stock
- ATH
- The first investment of the Action Fund was announced
The first investment of the Action Fund was announced, page-4
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $4.579K | 1.526M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 749591 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 133062022 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 749591 | 0.003 |
57 | 79202034 | 0.002 |
24 | 126310099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 132062022 | 25 |
0.005 | 21734306 | 24 |
0.006 | 23538946 | 18 |
0.007 | 52362650 | 23 |
0.008 | 41996117 | 30 |
Last trade - 14.03pm 13/09/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online